0001209191-20-050282.txt : 20200914 0001209191-20-050282.hdr.sgml : 20200914 20200914162422 ACCESSION NUMBER: 0001209191-20-050282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200914 DATE AS OF CHANGE: 20200914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Stephanie A CENTRAL INDEX KEY: 0001771886 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 201173395 MAIL ADDRESS: STREET 1: C/O ATHENEX, INC. STREET 2: 1001 MAIN STREET, SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-10 0 0001300699 Athenex, Inc. ATNX 0001771886 Davis Stephanie A C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 1 0 0 0 Common Stock 2020-09-10 4 P 0 10000 11.35 A 20000 D Stock Option (Right to Buy) 12.06 2029-04-01 Common Stock 10000 10000 D Stock Option (Right to Buy) 11.49 2029-04-03 Common Stock 7500 7500 D Stock Option (Right to Buy) 12.45 2030-06-05 Common Stock 17500 17500 D This option vests in four equal annual installments beginning on April 1, 2020. This option vests in four equal annual installments beginning on April 3, 2020. This option vests in four equal annual installments beginning on June 5, 2021. /s/Teresa Bair, Attorney-in-Fact 2020-09-14